REGN vs UI · P/E 14, rev $14.34B vs P/E 36, rev $2.57B
Regeneron Pharmaceuticals Inc (REGN) versus Ubiquiti Networks Inc (UI) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Ubiquiti Networks Inc (UI) is a communication equipment company listed on NYSE.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported UI revenue for 2025-06-30 was $2.57B. Net income was $711.9M. Revenue was up 33.4% from 2024-06-30 to 2025-06-30. UI currently screens at market cap $34.06B and trailing P/E 36.1.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. UI currently screens at market cap $34.06B and trailing P/E 36.1.
Not investment advice. Open the REGN and UI stock pages for the full models.
Not investment advice.